All liver biochemistry (ALT and AST), as well as apoptotic markers (fragmented CK-18), was significantly higher in NAFLD group compared to healthy subjects (p<0.001) (Table 4). This evidence concerns the gene KRT18 and metabolic dysfunction-associated steatotic liver disease.